| EPIC |
BVXP |
| Sector |
Pharma and Biotech |
| ISIN |
GB00B4QVDF07 |
| Market Sector |
AIM |
| Market Segment |
ASQ1 |
| Main Indices |
FTSE AIM All-Share, FTSE AIM 100 |
| Country of register |
Great Britain |
| Currency |
British Pound |
| Market Cap |
£121.48m |
| NMS |
200 |
| Shares in issue |
5.22m |
| Date Listed |
29-Apr-2014 |
| |
1st Interim |
2nd Interim |
| Ex-Div |
10-Apr-25 |
07-Nov-24 |
| Paid |
25-Apr-25 |
21-Nov-24 |
| Amount |
70.00p |
87.00p |
| 14:34 |
1 @ 2,272.00p |
| 14:24 |
212 @ 2,348.00p |
| 14:08 |
8 @ 2,348.00p |
| 14:06 |
1 @ 2,272.00p |
| 13:53 |
1 @ 2,272.00p |
| CEO |
Peter John Harrison |
| Chair |
Ian James Nicholson |
| CFO |
Bruce Hiscock |
Top of Page
You are here:
research